top of page

BRINGING SIGHT TO

BLIND PROCEDURES

Epidural precision needle guidance system

img-t_edited.jpg

Designed to meet
market needs

The BrightPointTM needle guidance system was designed to assist physicians with needle placement during spinal epidural procedures for childbirth and surgical procedures such as knee and hip replacements, joint injections, and pain management.

​

Designed to provide real-time visual guidance and confirmation for spinal epidural procedures, with the goal of reducing the number of training procedures required to achieve proficiency, the BrightPoint guidance system helps reduce complications and increase the success rate of epidural procedures.

Low Cost, Easy to Use Design

Needle guidance system composed of a portable handheld monitor plus a single-use, disposable fiber optic cable designed to fit in the lumen of existing epidural needles.

Real-time Visual Guidance

Designed to provide real-time visual confirmation of the tissue at the tip of the needle to provide secondary confirmation for epidural training procedures, with the aim of reducing the number of training procedures needed to gain proficiency, reducing complications, and increasing successful epidural procedures.

Operates Based on the Changes in Light Reflection 

The color of the tissue at the needle tip is displayed on the controller screen, along with a scrolling line graph showing the relative reflectance of the tissue at the needle tip.

Designed to be an Addition to Existing LOR Technology

The The device is designed to be an addition to - not a replacement for - the haptic Loss of Resistance (LOR) epidural technique currently used by anesthesiologists. It does not require any changes to the LOR method and works with the current needles and syringes.

Statistic Snapshot of LOR Market

$5B

Spent annually on epidural procedures in the US

11M+

Epidural procedures performed annually in US

30M

Epidural procedures performed annually worldwide

9 M

Pain intervention steroid injections performed in the US

2.4 M

Labor procedures performed annually in the US

Bright Point Medical
Current Market Status

$1.5M

Current VC investments

Patients participated in our human clinical trials

156

Are You Ready to Fund the Future of Epidural Technology?

Bright Point represents a significant leap forward in needle placement, offering visual accuracy and sensitivity. Our early success in our human clinical trial is a major milestone for us. These initiatives represent not only our commitment to the forefront of women's health but also underscore the potential for transformative impact in needle guidance.

 

This device can potentially revolutionize how we approach needle guidance, making epidurals, pain management and so many more uses, more feasible, accessible, and effective globally. We believe that Bright Point will become the standard of care for Epidurals.

bottom of page